• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

f-star Biotech

edit

f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. develops therapeutic antibodies and antibody fragments through modular antibody technology. Its modular antibody technology allows the introduction of additional binding sites into antibodies and antibody fragments by engineering the non-CDR loops of constant or variable domains. The company was founded in 2006 and is headquartered in Vienna, Austria. It has a research site in Cambridge, the United Kingdom.

Recent Milestones

edit

• 
  f-star Biotech received $21.7M (€15M) in Venture Round funding. (4/13/11)
  Posted 7/17/11 at 6:02pm via f-star.com
• 
  f-star Biotech received $11.5M (€8M) in Series A funding. (1/6/10)
  Posted 1/6/10 at 8:23pm via f-star.com
• 
  f-star Biotech received $4.42M (€3M) in Series A funding. (11/28/07)
  Posted 7/17/11 at 6:02pm via f-star.com
• 
  f-star Biotech received $8.28M (€6M) in Series A funding. (9/10/07)
  Posted 3/13/10 at 4:57am via f-star.com
• 
  f-star Biotech received $1.95M (€1.5M) in Seed funding. (1/8/07)
  Posted 7/17/11 at 6:02pm via f-star.com
• 
  f-star Biotech added Kevin FitzGerald as CEO.
  Posted 1/6/10 at 8:23pm
• 
  f-star Biotech added Eugen Stermetz as CFO.
  Posted 1/6/10 at 8:23pm

Videos

Screenshots

edit

Above: Home Page
Uploaded: 1/7/10

Sources

1. Antibody-Company F-Star Raises EUR1.5 million in Seed Financing Round From Atlas Venture (f-star.com) [edit]
2. Antibody Engineering Company F-Star Raises EUR 6.0 million in Series A Financing from Aescap Venture and Atlas Venture (f-star.com) [edit]
3. Antibody Engineering Company F-Star Raises EUR 3.0 million in a Second Closing of its Series A Financing Round from Novo A/S (f-star.com) [edit]
4. f-star raises €8m in an Extended Series A Financing co-led by MP Health-care Venture Management and Merck Serono Ventures (f-star.com) [edit]
5. f-star raises €15M in a New Financing led by SR One (f-star.com) [edit]